ANI Pharmaceuticals reported $225.65M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
AbbVie USD 12.48B 1.56B Mar/2025
ANI Pharmaceuticals USD 225.65M 5.32M Jun/2025
Aurora Cannabis CAD 39.14M 10.38M Jun/2025
Canopy Growth CAD 50.03M 972K Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Hikma Pharmaceutical USD 973M 8M Dec/2024
Knight Therapeutics CAD 103M 8.1M Sep/2024
Novartis USD 9.18B 1.62B Jun/2025
Perrigo USD 678.2M 38.6M Jun/2025
Sun Pharmaceuticals INR 130.94B 1.05B Mar/2025
Teva Pharmaceutical Industries USD 3.56B 180M Jun/2025